Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, September 5, 2023
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
[ Tue, Sep 05th 2023
] - WOPRAI
Ed Arce Reiterated (ARCT) at Strong Buy and Held Target at $51 on, Sep 5th, 2023
Ed Arce of HC Wainwright & Co., Reiterated "Arcturus Therapeutics Holdings Inc." (ARCT) at Strong Buy and Held Target at $51 on, Sep 5th, 2023.
Ed has made no other calls on ARCT in the last 4 months.
There are 3 other peers that have a rating on ARCT. Out of the 3 peers that are also analyzing ARCT, 0 agree with Ed's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Ed
- Pete Stavropoulos of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $54 on, Tuesday, August 22nd, 2023
- Myles Minter of "William Blair" Initiated at Buy and Held Target at $71 on, Monday, July 24th, 2023
- Seamus Fernandez of "Guggenheim" Maintained at Strong Buy on, Friday, July 14th, 2023
